C12N 2750/10034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2750/10034 (Use of virus or viral component as vaccine) appears on 205 US grants and 285 published applications in this corpus.
Search patents in C12N- Granted patents
- 205
- Published applications
- 285
- Assignees
- 82
- Inventors
- 374
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 4 |
| 2003 | 3 | 3 |
| 2004 | 2 | 11 |
| 2005 | 2 | 7 |
| 2006 | 4 | 8 |
| 2007 | 12 | 13 |
| 2008 | 7 | 15 |
| 2009 | 6 | 16 |
| 2010 | 16 | 24 |
| 2011 | 8 | 19 |
| 2012 | 2 | 5 |
| 2013 | 4 | 12 |
| 2014 | 5 | 10 |
| 2015 | 13 | 20 |
| 2016 | 9 | 16 |
| 2017 | 22 | 20 |
| 2018 | 23 | 10 |
| 2019 | 9 | 13 |
| 2020 | 13 | 13 |
| 2021 | 10 | 10 |
| 2022 | 4 | 9 |
| 2023 | 6 | 5 |
| 2024 | 5 | 9 |
| 2025 | 4 | 7 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- M Hyo multivalent vaccine and uses thereof16 Jun 2026US 12,653,876 B2
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Porcine circovirus type 2 VLP vaccine6 Jan 2026US 12,514,916 B2Meiji Animal Health Co., Ltd.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Porcine circovirus type 3 immunogenic compositions and methods of making and using the same17 Jun 2025US 12,331,080 B2Kansas State University Research Foundation
- Method of producing an immunogenic composition30 Jul 2026US 2026/0216312 A1Boehringer Ingelheim Animal Health USA Inc.
- Oil adjuvant compositions and vaccine emulsions comprising such oil adjuvant compositions23 Jul 2026US 2026/0207737 A1Ceva Sante Animale
- Methods and compositions of quaternary immunomodulatory nanoparticles for medical applications and immunotherapy25 Jun 2026US 2026/0174841 A1
- Identification of a human circovirus4 Jun 2026US 2026/0152812 A1
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Porcine circoviruses vaccines diagnostic reagents105US 6,391,314 B1Merial Limited · 2002
- Porcine circovirus vaccine and diagnostics reagents99US 6,368,601 B1Merial Limited · 2002
- Vaccines against circovirus infections85US 6,287,856 B1University of Georgia Research Foundation, Inc. · 2001
- Circovirus sequences associated with piglet weight loss disease (PWD)84US 6,703,023 B1Agence Francaise De Securite Sanitaire Des Aliments · 2004